Carson Tahoe Regional Medical Center
Clinical research site in Carson City, Nevada
As of July 2026, 24 paid clinical trials are recruiting at Carson Tahoe Regional Medical Center in Carson City, Nevada. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8 and Acute Lymphoblastic Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Carson Tahoe Regional Medical Center (24)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Mobile Health for Adherence in Breast Cancer Patients
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
Get new-trial alerts for Carson Tahoe Regional Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Carson City, NV. Unsubscribe anytime.
More research sites in Carson City
- Carson Tahoe Regional Healthcare (1 trial)
- Home-based telemedicine (1 trial)
- Nevada Health Centers (1 trial)
- Sierra Surgery Hospital (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Carson City, NV · Nevada clinical trials